Zobrazeno 1 - 10
of 152
pro vyhledávání: '"N V, Demidova"'
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 2, Pp 207-213 (2023)
The aim of the study was to study the features of the clinical picture of the disease in patients with ACPA-negative and ACPA-positive variants of rheumatoid arthritis.Materials and methods. The study included patients with a reliable diagnosis of rh
Externí odkaz:
https://doaj.org/article/5ebc5e669ce746bda799f439bd7dd45a
Publikováno v:
Современная ревматология, Vol 16, Iss 1, Pp 46-51 (2022)
Objective: to search for an association between basal expression of the AMP-activated protein kinase (adenosine monophosphate-activated protein kinase, AMPK) gene in the blood of patients with rheumatoid arthritis (RA) and disease activity, as well a
Externí odkaz:
https://doaj.org/article/f1a8e30906794c20891029aab43e7675
Publikováno v:
Научно-практическая ревматология, Vol 59, Iss 5, Pp 625-630 (2021)
Sarcoidosis is a rare multisystem disease which may accompany various autoimmune diseases in 17,6% cases. Despite of the fact that T-cell immunity impairments play a key role in these two conditions, their combination is extremely rare. It is difficu
Externí odkaz:
https://doaj.org/article/112e74e2e87843a390001d211aa27c91
Autor:
A. M. Satybaldyev, N. V. Demidova, G. I. Gridneva, N. Yu. Nikishina, E. V. Gerasimova, K. A. Kasumova, A. S. Misiyuk, O. A. Rumyantseva, E. A. Strebkova, V. N. Sorotskaya, N. V. Chichasova, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 1 (2022)
The question about the peculiarities of the course of rheumatoid arthritis in different age periods was raised in the literature repeatedly and the answer depended on the period of development of rheumatology and was not unambiguous. The course of ag
Externí odkaz:
https://doaj.org/article/adf35029596b4dbd944e5b27e80f23eb
Autor:
A. A. Mesnyankina, S. K. Solovyev, N. Yu. Nikishina, E. A. Aseeva, N. V. Demidova, E. L. Nasonov
Publikováno v:
Современная ревматология, Vol 14, Iss 4, Pp 31-38 (2020)
Objective: to determine the efficiency of sequential (combined) therapy with rituximab (RTM) and belimumab (BLM) in patients with active systemic lupus erythematosus (SLE).Patients and methods. Twelve patients with true SLE having moderate-to-high ac
Externí odkaz:
https://doaj.org/article/a593fe674bd241b8a837f49274f137fe
Autor:
A. M. Satybaldyev, N. V. Demidova, G. I. Gridneva, N. Yu. Nikishina, E. V. Gerasimova, D. A. Gukasian, K. A. Kasumova, E. L. Luchikhina, A. S. Misiyuk, T. G. Oskilko, O. A. Rumyantseva, E. A. Zlepko, L. N. Tyurina, E. V. Fedorenko, N. V. Shornikova, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 58, Iss 2, Pp 140-146 (2020)
The paper presents three cohorts of patients with early rheumatoid arthritis (RA) who fell ill at 50 years or older and had a disease duration of 1.5 months to 1 year. To establish its diagnosis, the investigators used classification criteria for eac
Externí odkaz:
https://doaj.org/article/f2fba16abc364e1db86601fe3e792f2d
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 47, Iss 5, Pp 383-392 (2019)
Background: Methotrexate is the main synthetic disease-modifying antirheumatic drug for the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA) and other immunoinflammatory conditions. In the recent years, the subcutaneous form of metho
Externí odkaz:
https://doaj.org/article/f5ce7276f303482b8e448dba529a6373
Publikováno v:
Современная ревматология, Vol 13, Iss 3, Pp 10-16 (2019)
Objective: to assess the presence and nature of multimorbidity in patients with rheumatoid arthritis (RA) and the impact of multimorbidity on disease activity.Patients and methods. The investigation enrolled 117 patients (mean age, 54.8+14.8years) wi
Externí odkaz:
https://doaj.org/article/96a94caa33014eeab899714fd1cd6945
Autor:
A. S. Avdeeva, A. M. Satybaldyev, N. V. Demidova, N. Yu. Nikishina, E. V. Gerasimova, N. V. Muravyeva, G. I. Gridneva, O. A. Rumyantseva, K. A. Kasumova, A. V. Alekseeva, N. V. Chichasova, D. A. Kusevich, V. V. Rybakova, E. A. Koshkarova, A. M. Lila, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 57, Iss 3, Pp 274-279 (2019)
Objective: to analyze therapy with rituximab (RTM) in real clinical practice according to the data available in OREL registry of patients with active rheumatoid arthritis (RA).Subjects and methods. The analysis included 349 patients. All the patients
Externí odkaz:
https://doaj.org/article/c83cabe4938a4829b645c10bcae3e0f2
Publikováno v:
Современная ревматология, Vol 13, Iss 2, Pp 47-54 (2019)
Rheumatoid arthritis (RA) is an autoimmune disease of unknown etiology, which is characterized by chronic erosive arthritis (synovitis) and systemic inflammation of the viscera. Methotrexate (MTX) is the drug of choice for RA treatment. However, it i
Externí odkaz:
https://doaj.org/article/3024a2022de3463bbddfe7e169e70716